Priser
Platform
Blog
Om os
Download
Arecor Therapeutics
Arecor Therapeutics
London Stock Exchange

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ARECOR THERAPEUTICS MED ENDAVU: Køb Arecor Therapeutics ($AREC) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Arecor Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Guangdong Hongda Holdings Group Co., Ltd. is a diversified holding company based in China. The company primarily operates in the real estate industry, focused on property development and management, and it holds interests in other sectors such as finance and investments. By leveraging its assets in land and real estate development projects, Guangdong Hongda Holdings Group Co., Ltd. aims to optimize asset management and enhance property value. The company has been involved in various large-scale developments, contributing to urbanization and infrastructure growth within Guangdong Province and beyond. Guangdong Hongda also invests in various financial products and services, which helps diversify its income streams and mitigate risks associated with the real estate market. Its strategic approach in blending real estate endeavors with financial investments underscores its significance in the market, providing comprehensive solutions and opportunities for growth in rapidly developing urban areas.

Information

Ticker002683
Land
Kina
Antal medarbejdere17.065
Hjemmesidehdbp.com
SektorRåstoffer
IndustriSpecialkemikalier

Udbytter

0,22CNH
'21
0,3CNH
'22
0,3CNH
'23
0,76CNH
'24
0,65CNH
'25
0,65CNH
'26
Ex-udbytte-dato10. sep. 2026
Udbytteafkast0,7%

Analytikerskøn

Baseret på 2 analytikere

Stærkt købKøbHoldSælgStærkt sælg
50%50%0%0%0%